PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
IDR 210.0
(0.0%)
IDR 210.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 145.69 Billion IDR | -24.47% |
| 2022 | 192.88 Billion IDR | -36.17% |
| 2021 | 302.18 Billion IDR | 64.97% |
| 2020 | 183.17 Billion IDR | 256.8% |
| 2019 | 51.33 Billion IDR | 33.16% |
| 2018 | 38.55 Billion IDR | 175.1% |
| 2017 | 14.01 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 41.74 Billion IDR | 8.2% |
| 2024 Q2 | 39.3 Billion IDR | -5.86% |
| 2023 Q2 | 33.57 Billion IDR | -10.79% |
| 2023 Q3 | 35.9 Billion IDR | 6.94% |
| 2023 Q1 | 37.63 Billion IDR | -23.28% |
| 2023 FY | 145.69 Billion IDR | -24.47% |
| 2023 Q4 | 38.58 Billion IDR | 7.46% |
| 2022 Q4 | 49.05 Billion IDR | 4.44% |
| 2022 Q3 | 46.97 Billion IDR | 20.54% |
| 2022 Q2 | 38.96 Billion IDR | -32.69% |
| 2022 FY | 192.88 Billion IDR | -36.17% |
| 2022 Q1 | 57.88 Billion IDR | 12.73% |
| 2021 Q1 | 87.87 Billion IDR | 6.54% |
| 2021 FY | 302.18 Billion IDR | 64.97% |
| 2021 Q4 | 51.35 Billion IDR | -37.41% |
| 2021 Q2 | 80.91 Billion IDR | -7.91% |
| 2021 Q3 | 82.04 Billion IDR | 1.39% |
| 2020 Q4 | 82.47 Billion IDR | 46.33% |
| 2020 Q1 | 15.63 Billion IDR | 6.36% |
| 2020 FY | 183.17 Billion IDR | 256.8% |
| 2020 Q2 | 28.7 Billion IDR | 83.62% |
| 2020 Q3 | 56.36 Billion IDR | 96.38% |
| 2019 Q3 | 14.69 Billion IDR | 33.92% |
| 2019 Q2 | 10.97 Billion IDR | 0.0% |
| 2019 FY | 51.33 Billion IDR | 33.16% |
| 2019 Q1 | 10.97 Billion IDR | 0.0% |
| 2019 Q4 | 14.69 Billion IDR | 0.0% |
| 2018 FY | 38.55 Billion IDR | 175.1% |
| 2017 FY | 14.01 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Prodia Widyahusada Tbk | 2222.46 Billion IDR | 93.444% |